Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3255 | Racial/Ethnic Frame Wiki | 1.00 |
| drug1376 | Emphasis of Academic Researchers Involvement Wiki | 1.00 |
| drug77 | A $10 Survey Incentive Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D003141 | Communicable Diseases NIH | 0.07 |
| D007239 | Infection NIH | 0.05 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The goal of this project is to help the state of Minnesota understand why individuals are not getting tested and potentially identify trusted individuals or organizations that could be used in follow-up work to send messages. Investigators focus on the first two issues of unit and item nonresponse, which is not random across the population and thus could lead to nonresponse bias. To do so, investigators are deploying flyers through 10 Twin City area food shelves and potentially through public housing units with information on how to answer an online questionnaire.
Description: Number of participants who received a flyer that mentions a $20 incentive and completed the survey
Measure: Effect of monetary incentives in increasing unit response 1 Time: This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes.Description: Number of participants who received a flyer that mentions a $10 incentive and completed the survey.
Measure: Effect of monetary incentives in increasing unit response 2 Time: This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes.Description: Number of participants who received a flyer that mentions a government frame and completed the survey
Measure: Effect of a government frame in reducing unit response 1 Time: This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes.Description: Number of participants who received a flyer that mentions a research frame and completed the survey.
Measure: Effect of a government frame in reducing unit response 2 Time: This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes.Description: Number of participants who received a flyer that mentions a government frame and $20 incentive and completed the survey
Measure: Interactions between monetary incentives and a government frame 1 Time: This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes.Description: Number of participants who received a flyer that mentions a government frame and $10 incentive and completed the survey
Measure: Interactions between monetary incentives and a government frame 2 Time: This outcome will be assessed when the individual agrees to participate in the Baseline survey, which takes approximately 20 minutes.Description: Number of participants who received a flyer that mentions a researcher frame and $20 incentive and completed the survey
Measure: Interactions between monetary incentives and a government frame 3 Time: This outcome will be assessed during the 20-minute Baseline Survey.Description: Number of participants who received a flyer that mentions a researcher frame and $10 incentive and completed the survey
Measure: Interactions between monetary incentives and a government frame 4 Time: This outcome will be assessed during the 20-minute Baseline Survey.Description: Demographic characteristics (e.g. sex, education level, income level, race/ethnicity) of participants who are assigned to each treatment arm and completed the survey.
Measure: Demographic characteristics of participants assigned into each treatment arm Time: This outcome will be assessed during the 20-minute Baseline Survey.Description: Number of survey participants who are randomly assigned to receive each messaging frame that: a) emphasizes the public health benefits of answering the survey questions (cost-benefit frame); b) emphasizes an individual's responsibility to their community (duty frame); c) emphasizes the disproportionate impact of COVID-19 on certain ethnic and racial groups; or d) provides no messaging.
Measure: Effect of various messaging frames in increasing item non-response Time: This outcome will be assessed during the 20-minute Baseline Survey.Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports